SCHEMBL6925932

SCHEMBL6925932

CC(C)c1csc2c(-c3ccncc3)cnc(N)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 6/20 0.54
KDR P35968 6/20 0.46
EPHB4 P54760 5/20 0.43
AURKB Q96GD4 2/20 0.40
FYN P06241 2/20 0.40
PLK4 O00444 1/20 0.40
AURKA O14965 1/20 0.40
MAPK13 O15264 1/20 0.40
PDPK1 O15530 1/20 0.40
JAK2 O60674 1/20 0.40
CHEK2 O96017 1/20 0.40
ABL1 P00519 1/20 0.40
NTRK1 P04629 1/20 0.40
INSR P06213 1/20 0.40
LCK P06239 1/20 0.40
CSF1R P07333 1/20 0.40
LYN P07948 1/20 0.40
MET P08581 1/20 0.40
KIT P10721 1/20 0.40
PIM1 P11309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924514 0.87 EPHB4 (0.58) BTKKDREPHB4CYP3A4BRAF
SCHEMBL10259827 0.81 BTK (0.57) BTKKDREPHB4AURKBFYN
SCHEMBL6927094 0.80 BTK (0.56) BTKKDREPHB4AURKBFYN
SCHEMBL3529709 0.80 BTK (0.59) BTKKDREPHB4AURKBFYN
SCHEMBL10198705 0.79 KDR (0.57) BTKKDRAURKBFYNPLK4
SCHEMBL3529981 0.77 BTK (0.70) BTKKDREPHB4AURKBFYN
SCHEMBL6924755 0.76 EPHB4 (0.35) BTKKDREPHB4AURKBFYN
SCHEMBL18611146 0.76 BTK (0.56) BTKKDRAURKBFYNPLK4
SCHEMBL6927096 0.75 EPHB4 (0.44) KDREPHB4AURKBFYNAURKA
SCHEMBL10198708 0.71 BTK (0.57) BTKMETALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018038-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2013-01-17 US disclosed
US-20130018038-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2013-01-17 US disclosed
US-20120077828-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-03-29 US disclosed
WO-2011119663-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018038-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R BTK 2336/4885KDR 3297/4885EPHB4 2288/4885
US-20120077828-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R BTK 2336/4885KDR 3297/4885EPHB4 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.